Jagsonpal Pharmaceuticals Profit & Loss account, Jagsonpal Pharmaceuticals Financial Statement & Accounts

YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals

BSE: 507789|NSE: JAGSNPHARM|ISIN: INE048B01027|SECTOR: Pharmaceuticals

SET ALERT

LIVE

BSE

May 21, 17:00

10.00

VOLUME 1,132

LIVE

NSE

May 21, 17:00

10.25

0.1 (0.99%)

VOLUME 3,277

Download Annual Report PDF Format 2011 | 2010

Standalone

Previous Years �

Profit & Loss account of Jagsonpal Pharmaceuticals

------------------- in Rs. Cr. -------------------

	Mar '12	Mar '11	Mar '10	Mar '09	Mar '08

	12 mths	12 mths	12 mths	12 mths	12 mths

Income
Sales Turnover	180.67	165.35	143.19	142.01	157.80
Excise Duty	4.15	4.40	3.59	5.82	7.71
Net Sales	176.52	160.95	139.60	136.19	150.09
Other Income	0.37	0.26	0.36	0.27	0.26
Stock Adjustments	10.74	-1.92	10.42	-7.87	-10.04
Total Income	187.63	159.29	150.38	128.59	140.31
Expenditure
Raw Materials	95.57	81.08	85.92	71.03	81.27
Power & Fuel Cost	2.52	2.05	1.44	1.24	1.23
Employee Cost	36.51	32.22	23.79	20.84	20.18
Other Manufacturing Expenses	0.03	0.38	0.33	0.64	0.16
Selling and Admin Expenses	0.00	11.27	10.66	10.82	10.54
Miscellaneous Expenses	36.00	17.50	12.15	8.29	13.70
Preoperative Exp Capitalised	0.00	0.00	0.00	0.00	0.00
Total Expenses	170.63	144.50	134.29	112.86	127.08
	Mar '12	Mar '11	Mar '10	Mar '09	Mar '08

	12 mths	12 mths	12 mths	12 mths	12 mths

Operating Profit	16.63	14.53	15.73	15.46	12.97
PBDIT	17.00	14.79	16.09	15.73	13.23
Interest	4.36	3.32	3.50	4.58	6.35
PBDT	12.64	11.47	12.59	11.15	6.88
Depreciation	2.54	2.20	2.08	1.25	1.69
Other Written Off	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	10.10	9.27	10.51	9.90	5.19
Extra-ordinary items	0.00	0.00	0.00	0.00	0.00
PBT (Post Extra-ord Items)	10.10	9.27	10.51	9.90	5.19
Tax	2.63	2.09	1.26	3.73	2.12
Reported Net Profit	7.46	7.18	9.24	6.17	3.08
Total Value Addition	75.06	63.42	48.37	41.84	45.81
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend	1.31	1.31	1.31	0.65	0.26
Corporate Dividend Tax	0.21	0.21	0.22	0.11	0.04
Per share data (annualised)
Shares in issue (lakhs)	261.98	261.98	261.98	261.98	261.98
Earning Per Share (Rs)	2.85	2.74	3.53	2.36	1.17
Equity Dividend (%)	10.00	10.00	10.00	5.00	2.00
Book Value (Rs)	37.59	30.25	28.09	25.15	23.08



Source : Dion Global Solutions Limited

Results of Jagson Pharma

News
Results
Estimates
Analysis

21.05.2013
Jagson Pharma board to consider dividend

14.05.2013
Jagsonpal Pharma appoints additional directors

22.04.2013
Jagson Pharma change in company secretary

15.02.2013
Jagson Pharma standalone Dec '12 sales at Rs 49.32 crore

More �

Results of Pharmaceuticals Sector

News
Results
Estimates
Analysis

22.05.2013
AstraZeneca Q4 net loss at Rs 19 crore

21.05.2013
Switch to Cipla from Ranbaxy Labs: Joshi

21.05.2013
Expect more weakness in Divis Laboratories: Joshi

21.05.2013
Venus Remedies standalone Mar '13 sales at Rs 125.32 crore

More �

Quick Links for jagsonpalpharmaceuticals

Corporate Action
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends

Peer Comparison
Competition
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Historical Prices
Price of Jagson%20Pharma on previous budgets

Related Searches jagsonpalpharmaceuticals Stock Price, Jagson%20Pharma Stock Quote, Jagson%20Pharma Results , Jagson%20Pharma News .. More »

Follow moneycontrol.com

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

Stocks A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Mutual Funds A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.